References
- Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. 2009. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–466.
- Bode W. 2006. Structure and interaction modes of thrombin. Blood Cells Mol Dis 36:122–130.
- Esfand R, Tomalia DA. 2001. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today 6:427–436.
- Farbiszewski R, Sokol A. 1988. The interaction between fibrinogen and 3H-L-arginine cationic peptides derived from fibrosarcoma in the presence of thrombin. Haematologia (Budap) 21:169–173.
- Fischer HC, Chan WC. 2007. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–571.
- Fruijtier-Polloth C. 2005. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology 214:1–38.
- Furie B, Furie BC. 2005. Thrombus formation in vivo. J Clin Invest 115:3355–3362.
- Gabellieri E, Strambini GB, Shcharbin D, Klajnert B, Bryszewska M. 2006. Dendrimer-protein interactions studied by tryptophan room temperature phosphorescence. Biochim Biophys Acta 1764:1750–1756.
- Hardman R. 2006. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165–172.
- Hermans J, McDonagh J. 1982. Fibrin: structure and interactions. Semin Thromb Hemost 8:11–24.
- Hudson SP, Padera RF, Langer R, Kohane DS. 2008. The biocompatibility of mesoporous silicates. Biomaterials 29(30):4045–4055.
- Jeong J, Cho W-S, Kim SH, Cho M-H. 2009. In Vitro and In Vivo Toxicity Study of Nanoparticles: John Wiley & Sons, Ltd. pp 303–334.
- Klajnert B, Stanislawska L, Bryszewska M, Palecz B. 2003. Interactions between PAMAM dendrimers and bovine serum albumin. Biochim Biophys Acta 1648:115–126.
- Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. 2007. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem 18:2054–2060.
- Lin W, Huang YW, Zhou XD, Ma Y. 2006. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217:252–259.
- Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, 2000. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133–148.
- Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
- Rijken DC. 1988. Relationships between structure and function of tissue-type plasminogen activator. Klin Wochenschr 66 Suppl 12:33–39.
- Saba HI, Herion JC, Walker RI, Roberts HR. 1975. Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system. Thromb Res 7:543–554.
- Service RF. 1995. Dendrimers: dream molecules approach real applications. Science 267:458–459.
- Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, 2010. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 31:5564–5574.
- Stober W, Fink A, Bohn E. 1968. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26:62–69.
- Svenson S, Tomalia DA. 2005. Dendrimers in biomedical applications–reflections on the field. Adv Drug Deliv Rev 57:2106–2129.
- Tomalia DA. 1994. Starburst/cascade dendrimers: fundamental building blocks for a new nanoscopic chemistry set. Adv Mater 6:529–539.
- Tomalia DA, Naylor AM, Goddard WA. 1990. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29:138–175.
- Van Blaaderen A, Vrij A. 1992. Synthesis and characterization of colloidal dispersions of fluorescent, monodisperse silica spheres. Langmuir 8:2921–2931.
- Vincenza Carriero M, Franco P, Vocca I, Alfano D, Longanesi-Cattani I, Bifulco K, 2009. Structure, function and antagonists of urokinase-type plasminogen activator. Front Biosci 14:3782–3794.
- Weetall HH. 1993. Preparation of immobilized proteins covalently coupled through silane coupling agents to inorganic supports. Appl Biochem Biotechnol 41:157–188.
- Wilbur DS, Pathare PM, Hamlin DK, Buhler KR, Vessella RL. 1998. Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjug Chem 9:813–825.
- Wolberg AS. 2007. Thrombin generation and fibrin clot structure. Blood Rev 21:131–142.